Jiebing Tang
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study.
Journal: Cancer letters
Published: November 18, 2025
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial.
Journal: Nature communications
Published: March 29, 2024
RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.
Journal: Acta biochimica et biophysica Sinica
Published: October 31, 2023
Advances and prospects of drug clinical research in colorectal cancer in 2022.
Journal: Cancer innovation
Published: December 26, 2022
5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Journal: Molecular oncology
Published: July 17, 2020
Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation.
Journal: Journal of molecular endocrinology
Published: March 14, 2020
LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway.
Journal: Journal of cellular physiology
Published: June 11, 2019
Identification of a novel STK11 gene mutation in a family affected with hereditary Peutz-Jeghers syndrome
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: February 09, 2018
Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: January 19, 2018
CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Journal: Oncology reports
Published: August 20, 2015
Last Updated: 09/26/2026